Не-антрациклиновая кардиотоксичность

The review presents the current data on cardiotoxicity of cytostatic drugs (excluding anthracycline antibiotics and drugs for targeted therapy), mechanisms of cardiotoxicity development, predictive factors, risk factors, clinical manifestations, cumulative doses and feasibility of preventing myocardial injuries